Braiin Ltd (NASDAQ:BRAI – Get Free Report)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $7.64, but opened at $7.23. Braiin shares last traded at $7.57, with a volume of 1,974 shares trading hands.
Braiin News Summary
Here are the key news stories impacting Braiin this week:
- Positive Sentiment: Maxim Group initiated coverage on Braiin Ltd (BRAI) with a Buy rating and a $10 price target, signaling analyst confidence and potential upside. Benzinga reference
- Neutral Sentiment: Several articles discussed brain research, memory, brain cancer treatment, and brain implants, but these appear to be broader science/health stories with no clear direct impact on Braiin Ltd’s stock. New York Times reference
- Neutral Sentiment: Additional lifestyle and wellness pieces about diet, bananas, gut health, scrolling, and clutter are unlikely to materially affect Braiin Ltd. MSN reference
Analyst Ratings Changes
A number of research firms have issued reports on BRAI. Weiss Ratings began coverage on Braiin in a research report on Wednesday, May 6th. They issued a “sell (e+)” rating on the stock. Maxim Group began coverage on Braiin in a research report on Monday. They issued a “buy” rating and a $10.00 target price on the stock. Finally, Wall Street Zen upgraded Braiin from a “sell” rating to a “hold” rating in a research report on Sunday, May 31st. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $10.00.
Braiin Price Performance
The company’s 50 day moving average price is $7.85.
Braiin Company Profile
Braiin Limited is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (“AI/ML”) technologies to deliver actionable insights across high-growth verticals: Agriculture, Property Technology, and Customer Experience as a Service (“CXaaS”). Our platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. Our first commercial focus is on the agriculture technology sector, where we have successfully deployed our AI-powered solutions across multiple implementations.
Featured Stories
- Five stocks we like better than Braiin
- AI Memory Demand Has Turned These 5 S&P 500 Stocks Into Market Leaders
- 3 Dividend Kings With Income, Stability, and a Possible Catalyst
- Plot Twist: How the $110B Paramount-Warner Deal Rewrites Media
- Goldman’s S&P 500 Target Looks More Reachable After the Latest Rally
Receive News & Ratings for Braiin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braiin and related companies with MarketBeat.com's FREE daily email newsletter.
